Enzyme replacement therapy and monitoring for children with type 1 Gaucher disease: Consensus recommendations

被引：77

作者：

Charrow, J

Andersson, HC

Kaplan, P

Kolodny, EH

Mistry, P

Pastores, G

Prakash-Cheng, A

Rosenbloom, BE

Scott, CR

Wappner, RS

Weinreb, NJ

机构：

[1] Childrens Mem Hosp, Div Genet, Chicago, IL 60614 USA

[2] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Chicago, IL 60611 USA

[3] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70118 USA

[4] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA

[5] Univ Penn, Philadelphia, PA 19104 USA

[6] NYU, Sch Med, Dept Neurol, New York, NY USA

[7] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA

[8] Mt Sinai Sch Med, Dept Human Genet, New York, NY USA

[9] Cedars Sinai Med Ctr, Dept Hematol & Oncol, Los Angeles, CA 90048 USA

[10] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA

[11] James Whitcomb Riley Hosp Children, Dept Pediat, Indianapolis, IN 46202 USA

[12] James Whitcomb Riley Hosp Children, Dept Med & Mol Genet, Indianapolis, IN 46202 USA

[13] Indiana Univ, Indianapolis, IN 46204 USA

[14] Univ Hosp, Dept Hematol, Tamarac, FL USA

来源：

JOURNAL OF PEDIATRICS | 2004年 / 144卷 / 01期

关键词：

D O I：

10.1016/j.jpeds.2003.10.067

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

[No abstract available]

引用

页码：112 / 120

页数：9

共 50 条

[21] COST-EFFECTIVENESS ANALYSIS OF ENZYME REPLACEMENT THERAPY FOR TYPE 1 GAUCHER DISEASE
Nabizadeh, A.
Davari, M.
Kadivar, M.
Asl, Abddollahi A.
VALUE IN HEALTH, 2018, 21 : S452 - S452
[22] Could enzyme replacement therapy promote immune tolerance in Gaucher disease type 1?
Matta, Marina Cadena
Vairo, Filippo
Torres, Leuridan Cavalcante
Schwartz, Ida
BLOOD CELLS MOLECULES AND DISEASES, 2018, 68 : 200 - 202
[23] Low dose enzyme replacement therapy in paediatric type 1 Gaucher's disease
Bembi, B
Donda, MG
Martini, C
Zanatta, M
Boscolo, R
Katouzian, F
Ciana, G
RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1998, 24 (01): : 93 - 98
[24] ENZYME REPLACEMENT THERAPY IN TYPE 1 GAUCHER DISEASE: A SINGLE CENTER'S EXPERIENCE
Mandala, E.
Lafaras, C.
Tsioni, K.
Michelakaki, H.
Koutalidou, S.
Ilonidis, G.
CLINICAL THERAPEUTICS, 2009, 31 : S209 - S210
[25] Bone Marrow Alteration in Patients With Type 1 Gaucher Disease on Enzyme Replacement Therapy
Lerner, D.
Simpson, W.
Hermann, G.
Balwani, M.
AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05)
[26] The budget impact of enzyme replacement therapy in type 1 Gaucher disease in the United States
Farahbakhshian, Sepehr
Inocencio, Timothy J.
Poorman, Gregory
Wright, Ekaterina
Pathak, Ravi Ramesh
Bullano, Michael
JOURNAL OF MEDICAL ECONOMICS, 2022, 25 (01) : 755 - 761
[27] Immunoglobulin Abnormalities and Effects of Enzyme Replacement Therapy in Children with Gaucher Disease
Arikan-Ayyildiz, Zeynep
Yuce, Aysel
Uslu-Kizilkan, Nuray
Demir, Hulya
Gurakan, Figen
PEDIATRIC BLOOD & CANCER, 2011, 56 (04) : 664 - 666
[28] Echocardiographic assessment in children with Gaucher disease receiving enzyme replacement therapy
Ayyildiz, Zeynep Arikan
Alehan, Dursun
Uslu, Nuray
Yuce, Aysel
Gurakan, Figen
ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, 2012, 12 (02): : 191 - 192
[29] An infant with type II Gaucher disease treated with enzyme replacement therapy
Ebihara, Go
Matsushita, Yuki
Kirino, Makiko
Hikino, Shunji
Sato, Kazuo
PEDIATRICS INTERNATIONAL, 2022, 64 (01)
[30] Enzyme replacement therapy in adult patients with type I Gaucher disease
Ponomarev, R., V
Lukina, E. A.
TERAPEVTICHESKII ARKHIV, 2019, 91 (07) : 127 - 131

← 1 2 3 4 5 →